Hugo Arasanz: specialist in Medical Oncology, specialized in thoracic oncology and central nervous system tumors, and Doctor of Health Sciences from the Public University of Navarra (2020). He actively participates in clinical trials, some of them as principal investigator, and was coordinator of the FER-FEN-2019-01 trial. In recent years he has participated in different basic/translational research projects with competitive funding, two of them as principal investigator, focused on cancer immunotherapy, biomarker studies, as well as treatment resistance and molecular pathways. He has more than 50 publications in indexed journals, with an h-index of 21.
